Nettle Pharmaceuticals Private Limited
About Nettle Pharmaceuticals Private Limited
Data last updated:
Nettle Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 15 October 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U33110DL2012PTC243599. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ravi Ranjan Kumar and Mohammad Murtuja.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at C – 1797 G/F (F/P) Parsadi Gali K.M.Pur(Kotla Mubarakpur) Near Dda Comun, Ity Centre, New Delhi, Delhi, India – 110003.
As per the financials filed for FY 2024, the company reported a revenue of ₹30,025, a decline of 74% compared to the previous year. For the same year it recorded a net loss of ₹500 (net margin -1.7%) and EBITDA of -₹500 (EBITDA margin -1.7%). Revenue has grown at a compounded annual rate (CAGR) of 35% over three years and 8% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Nettle Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressC – 1797 G/F (F/P) Parsadi Gali K.M.Pur(Kotla Mubarakpur) Near Dda Comun, Ity Centre, New Delhi, Delhi, India – 110003
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Nettle Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Nettle Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Nettle Pharmaceuticals Private Limited, buy the company report.
Financials of Nettle Pharmaceuticals Private Limited
FY 2024 filings availableNettle Pharmaceuticals Private Limited reported revenue of ₹30,025 (down 74% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 74% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 8%. EBITDA rose 92% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹500 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹500 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -1.7% | ||||
| Net Profit Margin | -1.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Nettle Pharmaceuticals Private Limited, buy the company report.
Board of directors of Nettle Pharmaceuticals Private Limited
Nettle Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ravi Ranjan Kumar | Director | 27 Apr 2018 | 8 Years 6 Months | Current |
| Mohammad Murtuja | Director | 15 Sep 2018 | 8 Years 1 Months | Current |
Auditor
Nettle Pharmaceuticals Private Limited is audited by DHANRAJ KESARI & CO for the financial year 2018.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| DHANRAJ KESARI & CO | FY 2018 | 025065N |
Shareholding
The shareholding of Nettle Pharmaceuticals Private Limited is on record for FY 2018, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2018 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Nettle Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Nettle Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Nettle Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Nettle Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Nettle Pharmaceuticals Private Limited, buy the company report.
Recent activity
Nettle Pharmaceuticals Private Limited has 5 board changes on record since 2018: 2 appointments and 3 cessations. The latest: Abhishek Kumar Mishra ceased to be Director on 28 Jun 2019.
Frequently asked questions
Nettle Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 15 October 2012 (14+ years old) and is registered under CIN U33110DL2012PTC243599.
Nettle Pharmaceuticals has 2 current directors:
- Ravi Ranjan Kumar - Director
- Mohammad Murtuja - Director
The latest financial statements of Nettle Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
No. Nettle Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Nettle Pharmaceuticals is U33110DL2012PTC243599. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nettle Pharmaceuticals was incorporated on 15 October 2012, making it 14+ years old. It is registered with the Registrar of Companies, Delhi.
Abhishek Kumar Mishra ceased to be Director on 28 Jun 2019. Rajesh Solanki ceased to be Director on 28 Jun 2019. Shobhna Singh ceased to be Director on 28 Jun 2019. Nettle Pharmaceuticals has 5 board changes on record in total.
The registered office of Nettle Pharmaceuticals is at C – 1797 GF FP Parsadi Gali K.M.PurKotla Mubarakpur Near Dda Comun, Ity Centre, New Delhi, Delhi, India – 110003.
Nettle Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Nettle Pharmaceuticals is compliant as of 25 September 2026. The company is actively filing with the Registrar of Companies.